nodes	percent_of_prediction	percent_of_DWPC	metapath
Prazosin—ORM1—saliva—nicotine dependence	0.0612	0.25	CbGeAlD
Prazosin—MT3—brain—nicotine dependence	0.0186	0.0759	CbGeAlD
Prazosin—KCNH7—brain—nicotine dependence	0.0186	0.0759	CbGeAlD
Prazosin—Eye pain—Varenicline—nicotine dependence	0.0142	0.0506	CcSEcCtD
Prazosin—KCNH6—brain—nicotine dependence	0.0133	0.0541	CbGeAlD
Prazosin—HTR1D—cardiovascular system—nicotine dependence	0.0112	0.0457	CbGeAlD
Prazosin—Angina pectoris—Varenicline—nicotine dependence	0.0108	0.0385	CcSEcCtD
Prazosin—Abdominal discomfort—Varenicline—nicotine dependence	0.0106	0.0379	CcSEcCtD
Prazosin—Pollakiuria—Varenicline—nicotine dependence	0.0103	0.0365	CcSEcCtD
Prazosin—Erectile dysfunction—Varenicline—nicotine dependence	0.0102	0.0364	CcSEcCtD
Prazosin—HTR1A—cardiovascular system—nicotine dependence	0.00934	0.0381	CbGeAlD
Prazosin—Epistaxis—Varenicline—nicotine dependence	0.00933	0.0332	CcSEcCtD
Prazosin—Bradycardia—Varenicline—nicotine dependence	0.00904	0.0322	CcSEcCtD
Prazosin—Hallucination—Varenicline—nicotine dependence	0.00884	0.0315	CcSEcCtD
Prazosin—HTR1D—midbrain—nicotine dependence	0.00875	0.0357	CbGeAlD
Prazosin—ADRA1A—cardiovascular system—nicotine dependence	0.00861	0.0351	CbGeAlD
Prazosin—KCNH2—cardiovascular system—nicotine dependence	0.00831	0.0339	CbGeAlD
Prazosin—Tinnitus—Varenicline—nicotine dependence	0.00828	0.0295	CcSEcCtD
Prazosin—ADRA1B—brain—nicotine dependence	0.00752	0.0306	CbGeAlD
Prazosin—ADRA1D—brain—nicotine dependence	0.00735	0.03	CbGeAlD
Prazosin—HTR1A—midbrain—nicotine dependence	0.00729	0.0297	CbGeAlD
Prazosin—Vision blurred—Varenicline—nicotine dependence	0.00729	0.026	CcSEcCtD
Prazosin—Ill-defined disorder—Varenicline—nicotine dependence	0.00718	0.0255	CcSEcCtD
Prazosin—Malaise—Varenicline—nicotine dependence	0.00697	0.0248	CcSEcCtD
Prazosin—Vertigo—Varenicline—nicotine dependence	0.00695	0.0247	CcSEcCtD
Prazosin—Syncope—Varenicline—nicotine dependence	0.00694	0.0247	CcSEcCtD
Prazosin—Palpitations—Varenicline—nicotine dependence	0.00683	0.0243	CcSEcCtD
Prazosin—Loss of consciousness—Varenicline—nicotine dependence	0.0068	0.0242	CcSEcCtD
Prazosin—Arthralgia—Varenicline—nicotine dependence	0.00658	0.0234	CcSEcCtD
Prazosin—Discomfort—Varenicline—nicotine dependence	0.0065	0.0232	CcSEcCtD
Prazosin—KCNH2—midbrain—nicotine dependence	0.00649	0.0265	CbGeAlD
Prazosin—Dry mouth—Varenicline—nicotine dependence	0.00644	0.0229	CcSEcCtD
Prazosin—Oedema—Varenicline—nicotine dependence	0.00631	0.0225	CcSEcCtD
Prazosin—Shock—Varenicline—nicotine dependence	0.00621	0.0221	CcSEcCtD
Prazosin—Tachycardia—Varenicline—nicotine dependence	0.00616	0.0219	CcSEcCtD
Prazosin—Hyperhidrosis—Varenicline—nicotine dependence	0.0061	0.0217	CcSEcCtD
Prazosin—ABCG2—midbrain—nicotine dependence	0.00578	0.0235	CbGeAlD
Prazosin—Musculoskeletal discomfort—Varenicline—nicotine dependence	0.00575	0.0205	CcSEcCtD
Prazosin—Insomnia—Varenicline—nicotine dependence	0.00571	0.0203	CcSEcCtD
Prazosin—Dyspnoea—Varenicline—nicotine dependence	0.00563	0.02	CcSEcCtD
Prazosin—Somnolence—Varenicline—nicotine dependence	0.00561	0.02	CcSEcCtD
Prazosin—SLC22A1—brain—nicotine dependence	0.00555	0.0226	CbGeAlD
Prazosin—ADRA1D—Monoamine GPCRs—DRD2—nicotine dependence	0.0055	0.0116	CbGpPWpGaD
Prazosin—HTR1D—brain—nicotine dependence	0.0055	0.0224	CbGeAlD
Prazosin—Fatigue—Varenicline—nicotine dependence	0.00544	0.0194	CcSEcCtD
Prazosin—ADRA1A—G alpha (12/13) signalling events—FGD1—nicotine dependence	0.00542	0.0114	CbGpPWpGaD
Prazosin—HTR1D—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00541	0.0114	CbGpPWpGaD
Prazosin—Pain—Varenicline—nicotine dependence	0.0054	0.0192	CcSEcCtD
Prazosin—Constipation—Varenicline—nicotine dependence	0.0054	0.0192	CcSEcCtD
Prazosin—SLC22A3—brain—nicotine dependence	0.0053	0.0216	CbGeAlD
Prazosin—Feeling abnormal—Varenicline—nicotine dependence	0.0052	0.0185	CcSEcCtD
Prazosin—ADRA2A—midbrain—nicotine dependence	0.00511	0.0208	CbGeAlD
Prazosin—KCNH7—Neuronal System—CHRNA3—nicotine dependence	0.00503	0.0106	CbGpPWpGaD
Prazosin—Urticaria—Varenicline—nicotine dependence	0.00501	0.0179	CcSEcCtD
Prazosin—Body temperature increased—Varenicline—nicotine dependence	0.00499	0.0178	CcSEcCtD
Prazosin—ADRA2B—Monoamine GPCRs—DRD2—nicotine dependence	0.00497	0.0105	CbGpPWpGaD
Prazosin—KCNH6—Neuronal System—CHRNB2—nicotine dependence	0.00497	0.0105	CbGpPWpGaD
Prazosin—HTR1A—Monoamine GPCRs—DRD2—nicotine dependence	0.0048	0.0101	CbGpPWpGaD
Prazosin—Hypersensitivity—Varenicline—nicotine dependence	0.00465	0.0166	CcSEcCtD
Prazosin—ADRA1D—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00463	0.00977	CbGpPWpGaD
Prazosin—HTR1A—brain—nicotine dependence	0.00458	0.0187	CbGeAlD
Prazosin—ADRA1B—Monoamine GPCRs—DRD2—nicotine dependence	0.00457	0.00964	CbGpPWpGaD
Prazosin—Asthenia—Varenicline—nicotine dependence	0.00453	0.0161	CcSEcCtD
Prazosin—KCNH6—Neuronal System—CHRNA4—nicotine dependence	0.00451	0.00952	CbGpPWpGaD
Prazosin—KCNH2—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00447	0.00944	CbGpPWpGaD
Prazosin—Pruritus—Varenicline—nicotine dependence	0.00447	0.0159	CcSEcCtD
Prazosin—KCNH7—Neuronal System—CHRNB2—nicotine dependence	0.00443	0.00934	CbGpPWpGaD
Prazosin—HTR1D—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00439	0.00926	CbGpPWpGaD
Prazosin—Diarrhoea—Varenicline—nicotine dependence	0.00432	0.0154	CcSEcCtD
Prazosin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2A7—nicotine dependence	0.00428	0.00903	CbGpPWpGaD
Prazosin—KCNH2—Neuronal System—CHRNB3—nicotine dependence	0.00428	0.00903	CbGpPWpGaD
Prazosin—KCNH7—Circadian rythm related genes—DRD2—nicotine dependence	0.00426	0.00898	CbGpPWpGaD
Prazosin—ADRA1A—brain—nicotine dependence	0.00422	0.0172	CbGeAlD
Prazosin—CYP1A1—Oxidation by Cytochrome P450—CYP2A7—nicotine dependence	0.00422	0.00891	CbGpPWpGaD
Prazosin—ADRA2B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00418	0.00882	CbGpPWpGaD
Prazosin—Dizziness—Varenicline—nicotine dependence	0.00417	0.0149	CcSEcCtD
Prazosin—KCNH2—brain—nicotine dependence	0.00408	0.0166	CbGeAlD
Prazosin—ADRA1A—Monoamine GPCRs—DRD2—nicotine dependence	0.00406	0.00856	CbGpPWpGaD
Prazosin—KCNH2—Neuronal System—CHRNA6—nicotine dependence	0.00405	0.00856	CbGpPWpGaD
Prazosin—HTR1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00403	0.00851	CbGpPWpGaD
Prazosin—KCNH7—Neuronal System—CHRNA4—nicotine dependence	0.00402	0.00849	CbGpPWpGaD
Prazosin—Vomiting—Varenicline—nicotine dependence	0.00401	0.0143	CcSEcCtD
Prazosin—Rash—Varenicline—nicotine dependence	0.00398	0.0142	CcSEcCtD
Prazosin—Dermatitis—Varenicline—nicotine dependence	0.00398	0.0142	CcSEcCtD
Prazosin—Headache—Varenicline—nicotine dependence	0.00395	0.0141	CcSEcCtD
Prazosin—ADRA1B—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00384	0.0081	CbGpPWpGaD
Prazosin—ADRA2A—Monoamine GPCRs—DRD2—nicotine dependence	0.00377	0.00796	CbGpPWpGaD
Prazosin—Nausea—Varenicline—nicotine dependence	0.00375	0.0133	CcSEcCtD
Prazosin—ABCB1—cardiovascular system—nicotine dependence	0.00365	0.0149	CbGeAlD
Prazosin—ABCG2—brain—nicotine dependence	0.00363	0.0148	CbGeAlD
Prazosin—SLC22A2—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00348	0.00735	CbGpPWpGaD
Prazosin—CYP1A1—Phase 1 - Functionalization of compounds—CYP2A7—nicotine dependence	0.00347	0.00732	CbGpPWpGaD
Prazosin—CYP1A1—brain—nicotine dependence	0.00345	0.014	CbGeAlD
Prazosin—ADRA1A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00341	0.0072	CbGpPWpGaD
Prazosin—ADRA2B—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00339	0.00716	CbGpPWpGaD
Prazosin—SLC22A2—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.0033	0.00697	CbGpPWpGaD
Prazosin—HTR1A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00327	0.00691	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—CHRNB3—nicotine dependence	0.00325	0.00685	CbGpPWpGaD
Prazosin—ADRA2A—brain—nicotine dependence	0.00321	0.0131	CbGeAlD
Prazosin—ADRA2A—Amine ligand-binding receptors—DRD2—nicotine dependence	0.00317	0.00669	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—CHRNA6—nicotine dependence	0.00308	0.0065	CbGpPWpGaD
Prazosin—KCNH2—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00299	0.0063	CbGpPWpGaD
Prazosin—KCNH2—Neuronal System—GABRA4—nicotine dependence	0.00293	0.00619	CbGpPWpGaD
Prazosin—ABCB1—midbrain—nicotine dependence	0.00285	0.0116	CbGeAlD
Prazosin—KCNH2—Neuronal System—CHRNB4—nicotine dependence	0.00281	0.00593	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—CHRNB4—nicotine dependence	0.00281	0.00592	CbGpPWpGaD
Prazosin—KCNH2—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.00271	0.00572	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—CHRNB3—nicotine dependence	0.00267	0.00563	CbGpPWpGaD
Prazosin—HTR1D—GPCR ligand binding—TAS2R16—nicotine dependence	0.00266	0.00561	CbGpPWpGaD
Prazosin—KCNH2—Neuronal System—CHRNA5—nicotine dependence	0.00261	0.00551	CbGpPWpGaD
Prazosin—ADRA2A—G alpha (i) signalling events—TAS2R16—nicotine dependence	0.00257	0.00543	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—CHRNA6—nicotine dependence	0.00253	0.00534	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—CHRNB3—nicotine dependence	0.00249	0.00525	CbGpPWpGaD
Prazosin—SLC22A2—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00239	0.00504	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—CHRNA6—nicotine dependence	0.00236	0.00498	CbGpPWpGaD
Prazosin—SLC22A2—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00229	0.00483	CbGpPWpGaD
Prazosin—ADRA1D—GPCR ligand binding—TAS2R16—nicotine dependence	0.00227	0.0048	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—GABRA4—nicotine dependence	0.00223	0.0047	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—CHRNB4—nicotine dependence	0.00213	0.0045	CbGpPWpGaD
Prazosin—KCNH2—Neuronal System—CHRNA3—nicotine dependence	0.00213	0.00449	CbGpPWpGaD
Prazosin—SLC22A2—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00213	0.00449	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00205	0.00433	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—CHRNA5—nicotine dependence	0.00198	0.00419	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00198	0.00418	CbGpPWpGaD
Prazosin—CYP1A1—Metapathway biotransformation—AKR1B10—nicotine dependence	0.00195	0.00412	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—TAS2R16—nicotine dependence	0.00189	0.00398	CbGpPWpGaD
Prazosin—KCNH2—Neuronal System—CHRNB2—nicotine dependence	0.00187	0.00396	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—CHRNB2—nicotine dependence	0.00187	0.00395	CbGpPWpGaD
Prazosin—HTR1D—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00185	0.0039	CbGpPWpGaD
Prazosin—CYP1A1—Biological oxidations—CYP2A7—nicotine dependence	0.00184	0.00389	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—GABRA4—nicotine dependence	0.00183	0.00386	CbGpPWpGaD
Prazosin—CYP1A1—Metapathway biotransformation—CYP2A7—nicotine dependence	0.00182	0.00383	CbGpPWpGaD
Prazosin—ABCB1—brain—nicotine dependence	0.00179	0.00729	CbGeAlD
Prazosin—SLC22A2—Neuronal System—CHRNB4—nicotine dependence	0.00175	0.0037	CbGpPWpGaD
Prazosin—SLC22A2—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00173	0.00366	CbGpPWpGaD
Prazosin—HTR1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00172	0.00362	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—GABRA4—nicotine dependence	0.0017	0.0036	CbGpPWpGaD
Prazosin—KCNH2—Neuronal System—CHRNA4—nicotine dependence	0.0017	0.00359	CbGpPWpGaD
Prazosin—HTR1A—SIDS Susceptibility Pathways—CHRNA4—nicotine dependence	0.0017	0.00359	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00168	0.00354	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—CHRNB4—nicotine dependence	0.00163	0.00345	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—CHRNA5—nicotine dependence	0.00163	0.00344	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—CHRNA3—nicotine dependence	0.00162	0.00341	CbGpPWpGaD
Prazosin—SLC22A3—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.00157	0.00331	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—TAS2R16—nicotine dependence	0.00156	0.00329	CbGpPWpGaD
Prazosin—SLC22A2—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00153	0.00322	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—CHRNA5—nicotine dependence	0.00152	0.00321	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.0015	0.00317	CbGpPWpGaD
Prazosin—HTR1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00147	0.0031	CbGpPWpGaD
Prazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00147	0.0031	CbGpPWpGaD
Prazosin—ADRA2B—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00143	0.00302	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—CHRNB2—nicotine dependence	0.00142	0.003	CbGpPWpGaD
Prazosin—SLC22A2—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00139	0.00293	CbGpPWpGaD
Prazosin—HTR1A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00138	0.00291	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.00136	0.00288	CbGpPWpGaD
Prazosin—HTR1D—G alpha (i) signalling events—DRD2—nicotine dependence	0.00134	0.00282	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—CHRNA3—nicotine dependence	0.00133	0.0028	CbGpPWpGaD
Prazosin—ADRA2B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00133	0.0028	CbGpPWpGaD
Prazosin—SLC22A1—Transmission across Chemical Synapses—CHRNA4—nicotine dependence	0.00129	0.00273	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00129	0.00271	CbGpPWpGaD
Prazosin—HTR1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00128	0.0027	CbGpPWpGaD
Prazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00126	0.00266	CbGpPWpGaD
Prazosin—HTR1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00124	0.00262	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—CHRNA3—nicotine dependence	0.00124	0.00261	CbGpPWpGaD
Prazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00122	0.00257	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—FGD1—nicotine dependence	0.00118	0.00249	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—CHRNB2—nicotine dependence	0.00117	0.00247	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—TAS2R16—nicotine dependence	0.00117	0.00246	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00116	0.00245	CbGpPWpGaD
Prazosin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00114	0.0024	CbGpPWpGaD
Prazosin—HTR1D—GPCR ligand binding—OPRM1—nicotine dependence	0.00112	0.00236	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00112	0.00236	CbGpPWpGaD
Prazosin—HTR1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.0011	0.00232	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—CHRNB2—nicotine dependence	0.00109	0.0023	CbGpPWpGaD
Prazosin—ADRA2A—G alpha (i) signalling events—OPRM1—nicotine dependence	0.00108	0.00229	CbGpPWpGaD
Prazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00108	0.00229	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—FGD1—nicotine dependence	0.00107	0.00226	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00107	0.00225	CbGpPWpGaD
Prazosin—HTR1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00106	0.00224	CbGpPWpGaD
Prazosin—SLC22A2—Neuronal System—CHRNA4—nicotine dependence	0.00106	0.00224	CbGpPWpGaD
Prazosin—ADRA1D—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.00106	0.00224	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—TAS2R16—nicotine dependence	0.00105	0.00222	CbGpPWpGaD
Prazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.00104	0.00221	CbGpPWpGaD
Prazosin—ADRA2B—G alpha (i) signalling events—DRD2—nicotine dependence	0.00103	0.00218	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00102	0.00215	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—FGD1—nicotine dependence	0.00101	0.00213	CbGpPWpGaD
Prazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—OPRM1—nicotine dependence	0.00101	0.00212	CbGpPWpGaD
Prazosin—HTR1A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000998	0.00211	CbGpPWpGaD
Prazosin—ABCG2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000994	0.0021	CbGpPWpGaD
Prazosin—SLC22A1—Neuronal System—CHRNA4—nicotine dependence	0.00099	0.00209	CbGpPWpGaD
Prazosin—SLC22A2—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000983	0.00208	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—TAS2R16—nicotine dependence	0.000969	0.00204	CbGpPWpGaD
Prazosin—ADRA2B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000959	0.00202	CbGpPWpGaD
Prazosin—ADRA1D—GPCR ligand binding—OPRM1—nicotine dependence	0.000959	0.00202	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.000947	0.002	CbGpPWpGaD
Prazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000928	0.00196	CbGpPWpGaD
Prazosin—HTR1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000926	0.00195	CbGpPWpGaD
Prazosin—SLC22A1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000917	0.00193	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—FGD1—nicotine dependence	0.000916	0.00193	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—FGD1—nicotine dependence	0.00091	0.00192	CbGpPWpGaD
Prazosin—ADRA1D—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.00091	0.00192	CbGpPWpGaD
Prazosin—ADRA1B—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000882	0.00186	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—TAS2R16—nicotine dependence	0.00088	0.00186	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000879	0.00185	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—OPRM1—nicotine dependence	0.000865	0.00183	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OPRM1—nicotine dependence	0.000862	0.00182	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—TAS2R16—nicotine dependence	0.00086	0.00182	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—FGD1—nicotine dependence	0.000837	0.00177	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000835	0.00176	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—FGD1—nicotine dependence	0.000827	0.00174	CbGpPWpGaD
Prazosin—ADRA2B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000822	0.00173	CbGpPWpGaD
Prazosin—HTR1D—GPCR ligand binding—DRD2—nicotine dependence	0.00081	0.00171	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000805	0.0017	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—TAS2R16—nicotine dependence	0.000799	0.00169	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—FGD1—nicotine dependence	0.000798	0.00168	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—OPRM1—nicotine dependence	0.000796	0.00168	CbGpPWpGaD
Prazosin—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000793	0.00167	CbGpPWpGaD
Prazosin—ADRA2A—G alpha (i) signalling events—DRD2—nicotine dependence	0.000784	0.00165	CbGpPWpGaD
Prazosin—ADRA1A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000783	0.00165	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—FGD1—nicotine dependence	0.00076	0.0016	CbGpPWpGaD
Prazosin—ADRA1B—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000755	0.00159	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—FGD1—nicotine dependence	0.000743	0.00157	CbGpPWpGaD
Prazosin—SLC22A3—Metabolism—CYP2A7—nicotine dependence	0.000734	0.00155	CbGpPWpGaD
Prazosin—ADRA2A—GPCRs, Class A Rhodopsin-like—DRD2—nicotine dependence	0.000728	0.00154	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—OPRM1—nicotine dependence	0.000707	0.00149	CbGpPWpGaD
Prazosin—ADRA1D—GPCR ligand binding—DRD2—nicotine dependence	0.000693	0.00146	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—FGD1—nicotine dependence	0.000691	0.00146	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—TAS2R16—nicotine dependence	0.000689	0.00145	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—FGD1—nicotine dependence	0.000675	0.00142	CbGpPWpGaD
Prazosin—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000671	0.00142	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—OPRM1—nicotine dependence	0.000657	0.00139	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000633	0.00134	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—FGD1—nicotine dependence	0.000632	0.00133	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—FGD1—nicotine dependence	0.000627	0.00132	CbGpPWpGaD
Prazosin—ADRA2B—GPCR ligand binding—DRD2—nicotine dependence	0.000626	0.00132	CbGpPWpGaD
Prazosin—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—nicotine dependence	0.000623	0.00132	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—TAS2R16—nicotine dependence	0.000622	0.00131	CbGpPWpGaD
Prazosin—HTR1A—GPCR ligand binding—DRD2—nicotine dependence	0.000604	0.00127	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000601	0.00127	CbGpPWpGaD
Prazosin—ADRA1B—GPCR ligand binding—DRD2—nicotine dependence	0.000575	0.00121	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000575	0.00121	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—TAS2R16—nicotine dependence	0.000572	0.00121	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000558	0.00118	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—OPRM1—nicotine dependence	0.000542	0.00114	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—FGD1—nicotine dependence	0.000541	0.00114	CbGpPWpGaD
Prazosin—ABCB1—Transmembrane transport of small molecules—GABRA4—nicotine dependence	0.000537	0.00113	CbGpPWpGaD
Prazosin—ADRA1A—GPCR ligand binding—DRD2—nicotine dependence	0.000511	0.00108	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—TAS2R16—nicotine dependence	0.000508	0.00107	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—OPRM1—nicotine dependence	0.000492	0.00104	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—OPRM1—nicotine dependence	0.000489	0.00103	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—FGD1—nicotine dependence	0.000488	0.00103	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—AKR1B10—nicotine dependence	0.000478	0.00101	CbGpPWpGaD
Prazosin—ADRA2A—GPCR ligand binding—DRD2—nicotine dependence	0.000475	0.001	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—TAS2R16—nicotine dependence	0.000472	0.000997	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000472	0.000996	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—FGD1—nicotine dependence	0.000471	0.000995	CbGpPWpGaD
Prazosin—ABCG2—Metabolism—CYP2A7—nicotine dependence	0.000465	0.000982	CbGpPWpGaD
Prazosin—SLC22A2—Metabolism—CYP2A7—nicotine dependence	0.000461	0.000972	CbGpPWpGaD
Prazosin—HTR1D—GPCR downstream signaling—DRD2—nicotine dependence	0.000458	0.000966	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—OPRM1—nicotine dependence	0.00045	0.000949	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—FGD1—nicotine dependence	0.000449	0.000948	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—OPRM1—nicotine dependence	0.000444	0.000937	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—AKR1B10—nicotine dependence	0.000431	0.00091	CbGpPWpGaD
Prazosin—SLC22A1—Metabolism—CYP2A7—nicotine dependence	0.000429	0.000906	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000429	0.000905	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000416	0.000879	CbGpPWpGaD
Prazosin—HTR1D—Signaling by GPCR—DRD2—nicotine dependence	0.000416	0.000877	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—OPRM1—nicotine dependence	0.000408	0.000862	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000399	0.000843	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—FGD1—nicotine dependence	0.000399	0.000842	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—AKR1B10—nicotine dependence	0.000397	0.000837	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—WASF2—nicotine dependence	0.000393	0.00083	CbGpPWpGaD
Prazosin—ADRA1D—GPCR downstream signaling—DRD2—nicotine dependence	0.000392	0.000827	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—WASF1—nicotine dependence	0.000377	0.000796	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—OPRM1—nicotine dependence	0.000371	0.000783	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—FGD1—nicotine dependence	0.000371	0.000782	CbGpPWpGaD
Prazosin—ADRA2A—Metabolism—CYP2A7—nicotine dependence	0.000364	0.000768	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—OPRM1—nicotine dependence	0.000363	0.000765	CbGpPWpGaD
Prazosin—ADRA1D—Signaling by GPCR—DRD2—nicotine dependence	0.000356	0.000751	CbGpPWpGaD
Prazosin—ADRA2B—GPCR downstream signaling—DRD2—nicotine dependence	0.000354	0.000746	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—AKR1B10—nicotine dependence	0.000352	0.000743	CbGpPWpGaD
Prazosin—HTR1A—GPCR downstream signaling—DRD2—nicotine dependence	0.000341	0.00072	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—OPRM1—nicotine dependence	0.00034	0.000717	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—OPRM1—nicotine dependence	0.000337	0.000711	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—WASF2—nicotine dependence	0.000337	0.000711	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—AKR1B10—nicotine dependence	0.000327	0.000691	CbGpPWpGaD
Prazosin—ADRA1B—GPCR downstream signaling—DRD2—nicotine dependence	0.000325	0.000686	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—WASF1—nicotine dependence	0.000323	0.000681	CbGpPWpGaD
Prazosin—ADRA2B—Signaling by GPCR—DRD2—nicotine dependence	0.000321	0.000678	CbGpPWpGaD
Prazosin—CYP1A1—Metabolism—CYP2A7—nicotine dependence	0.000315	0.000665	CbGpPWpGaD
Prazosin—HTR1A—Signaling by GPCR—DRD2—nicotine dependence	0.00031	0.000654	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—WASF2—nicotine dependence	0.000304	0.000641	CbGpPWpGaD
Prazosin—ADRA1B—Signaling by GPCR—DRD2—nicotine dependence	0.000295	0.000623	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—WASF2—nicotine dependence	0.000293	0.000619	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—WASF1—nicotine dependence	0.000291	0.000615	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—OPRM1—nicotine dependence	0.000291	0.000613	CbGpPWpGaD
Prazosin—ADRA1A—GPCR downstream signaling—DRD2—nicotine dependence	0.000289	0.000609	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—WASF1—nicotine dependence	0.000281	0.000594	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—WASF2—nicotine dependence	0.000279	0.00059	CbGpPWpGaD
Prazosin—ADRA2A—GPCR downstream signaling—DRD2—nicotine dependence	0.000268	0.000566	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—WASF1—nicotine dependence	0.000268	0.000565	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—OPRM1—nicotine dependence	0.000262	0.000554	CbGpPWpGaD
Prazosin—ADRA1A—Signaling by GPCR—DRD2—nicotine dependence	0.000262	0.000553	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—OPRM1—nicotine dependence	0.000253	0.000535	CbGpPWpGaD
Prazosin—ABCB1—Metabolism—CYP2A7—nicotine dependence	0.000252	0.000531	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—WASF2—nicotine dependence	0.000248	0.000524	CbGpPWpGaD
Prazosin—HTR1D—Signaling Pathways—DRD2—nicotine dependence	0.000245	0.000518	CbGpPWpGaD
Prazosin—ADRA2A—Signaling by GPCR—DRD2—nicotine dependence	0.000244	0.000514	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—OPRM1—nicotine dependence	0.000241	0.000509	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—WASF1—nicotine dependence	0.000238	0.000502	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—WASF2—nicotine dependence	0.000231	0.000487	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—WASF1—nicotine dependence	0.000221	0.000467	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—OPRM1—nicotine dependence	0.000214	0.000452	CbGpPWpGaD
Prazosin—ADRA1D—Signaling Pathways—DRD2—nicotine dependence	0.00021	0.000443	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—OPRM1—nicotine dependence	0.000199	0.00042	CbGpPWpGaD
Prazosin—ADRA2B—Signaling Pathways—DRD2—nicotine dependence	0.00019	0.0004	CbGpPWpGaD
Prazosin—HTR1A—Signaling Pathways—DRD2—nicotine dependence	0.000183	0.000386	CbGpPWpGaD
Prazosin—ADRA1B—Signaling Pathways—DRD2—nicotine dependence	0.000174	0.000368	CbGpPWpGaD
Prazosin—ADRA1A—Signaling Pathways—DRD2—nicotine dependence	0.000155	0.000327	CbGpPWpGaD
Prazosin—ADRA2A—Signaling Pathways—DRD2—nicotine dependence	0.000144	0.000304	CbGpPWpGaD
